Category Archives: Media Coverage

Business of Biotech: Biotech M&A Anomalies With Allan Shaw

...

CancerNetwork: Nicholas Coupe, MBBS, PhD, Provides Update on Phase 2 Study of IMM60 in Advanced Melanoma/NSCLC

...

ENDPOINTS: Bristol Myers vets tie up another all-stock deal, lining up clinical-stage oncology pipeline

...

Molecule to Market: Biotech trends you need to know

...

BioProcess Insider: Portage targets adenosine pathway with Tarus acquisition

...

BioSpace: Portage Adds Four Adenosine Candidates to Pipeline in Tarus Buyout

...

Fierce Biotech: Portage raids fellow biotech Tarus for adenosine receptor treasures

...

ENDPOINTS: Low-profile biotech led by Bristol Myers vets grabs a suite of adenosine receptor antagonists via tiny buyout

...

OncologyTube: Melanoma & CD8 Killer T Cells

...

PharmaShots: In Conversation with Portage’s CEO and Director, Dr. Ian Walters, Where he Shares Insights on Ongoing Clinical-Stage and Development Programs

...